Literature DB >> 11711469

Absence of viral nucleic acids in early and late dilated cardiomyopathy.

N G Mahon1, B Zal, G Arno, P Risley, J Pinto-Basto, W J McKenna, M J Davies, C Baboonian.   

Abstract

OBJECTIVE: To investigate whether viral infection acts as a trigger factor for the development of dilated cardiomyopathy in genetically predisposed individuals with a family history of disease.
SETTING: Patients attending the cardiomyopathy unit in a cardiac tertiary referral centre.
DESIGN: Nested polymerase chain reaction (nPCR) was used to determine whether enteroviral, adenoviral, or cytomegaloviral nucleic acids were detectable in the myocardium of 19 asymptomatic relatives of patients with dilated cardiomyopathy; all these relatives had echocardiographic abnormalities thought to represent early disease. Explanted hearts from patients with end stage dilated cardiomyopathy were also studied and were compared with 25 controls (ischaemic heart disease (21), valvar heart disease (2), hypertrophic cardiomyopathy (1), restrictive cardiomyopathy (1)). Myocardial tissue from two fatal cases of culture positive coxsackie myocarditis was used as a positive control.
RESULTS: No viral nucleic acid was detected in any group other than in those with myocarditis. Spiking of random wells with purified recombinant viral nucleic acids confirmed the sensitivity and reproducibility of the assays.
CONCLUSIONS: Myocardial viral infection is not detectable in relatives of patients with dilated cardiomyopathy who are suspected of having early disease. There is no evidence that viruses act as a trigger factor for initiating the dilated cardiomyopathy in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711469      PMCID: PMC1730028          DOI: 10.1136/heart.86.6.687

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  34 in total

1.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

2.  Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy.

Authors:  P Muir; F Nicholson; S J Illavia; T S McNeil; J F Ajetunmobi; H Dunn; W G Starkey; K N Reetoo; N R Cary; J Parameshwar; J E Banatvala
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

3.  Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.

Authors:  H J Why; B T Meany; P J Richardson; E G Olsen; N E Bowles; L Cunningham; C A Freeke; L C Archard
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

4.  Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction.

Authors:  P J Keeling; S Jeffery; A L Caforio; R Taylor; G F Bottazzo; M J Davies; W J McKenna
Journal:  Br Heart J       Date:  1992-12

5.  Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy.

Authors:  B Kyu; A Matsumori; Y Sato; I Okada; N M Chapman; S Tracy
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

6.  Detection of enteroviruses in endomyocardial biopsy by molecular approach.

Authors:  J Petitjean; H Kopecka; F Freymuth; J M Langlard; P Scanu; F Galateau; J B Bouhour; M Ferrière; P Charbonneau; M Komajda
Journal:  J Med Virol       Date:  1992-05       Impact factor: 2.327

7.  Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy.

Authors:  M Giacca; G M Severini; L Mestroni; A Salvi; G Lardieri; A Falaschi; F Camerini
Journal:  J Am Coll Cardiol       Date:  1994-10       Impact factor: 24.094

8.  Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathy.

Authors:  J A Liljeqvist; T Bergström; S Holmström; A Samuelson; G E Yousef; F Waagstein; S Jeansson
Journal:  J Med Virol       Date:  1993-01       Impact factor: 2.327

9.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984.

Authors:  M B Codd; D D Sugrue; B J Gersh; L J Melton
Journal:  Circulation       Date:  1989-09       Impact factor: 29.690

10.  Evidence from family studies for autoimmunity in dilated cardiomyopathy.

Authors:  A L Caforio; P J Keeling; E Zachara; L Mestroni; F Camerini; J M Mann; G F Bottazzo; W J McKenna
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

View more
  3 in total

1.  Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.

Authors:  G Arno; J C Kaski; D A Smith; J P Akiyu; S E Hughes; C Baboonian
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

2.  The role of viral infections in the development of dilated cardiomyopathy.

Authors:  Eniko Tátrai; István Hartyánszky; András Lászik; György Acsády; Péter Sótonyi; Márta Hubay
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

Review 3.  Coxsackieviral replication and pathogenicity: lessons from gene modified animal models.

Authors:  Rainer Wessely
Journal:  Med Microbiol Immunol       Date:  2003-10-25       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.